FDA Grants Approval For Eli Lilly's Selpercatinib For Patients With Locally Advanced Or Metastatic Solid Tumors With A RET Gene Fusion

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-traditional-approval-selpercatinib-locally-advanced-or-metastatic-ret-fusion-positive